CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

• The State Of The Clinical Development Race

  Every medicine reaching a patient has run a race from a crowded grid of candidates through the clinical development circuit to the market launch podium. Catch up on what’s in store for this season.

• Examining The New Look For Biotech

  According to a recent episode of Citeline’s podcast series, “Small Biotechs, Big Decisions,” biotech is developing a new look that is leaner and savvier when it comes to working with partners.

• How AI Is Revolutionizing Clinical Development

  Artificial intelligence is expanding from the preclinical phase of clinical trials into Phases I–III, where is it being used in protocol design, site selection, feasibility, and patient recruitment.

• Matching Pharmacovigilance Methodology To Organizational Scale

  One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.

• AI Tools In Informed Consent: What Sponsors Need To Know About Risk

  AI tools carry different risks. See how they can impact participant communications, where bias and inaccuracies emerge, and why human review is critical to protecting study integrity.